http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 10 Jul 2026 11:12:30 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html <p>Investing.com -- JPMorgan released its list of top short ideas for the third quarter of 2026, featuring selections from its highest-ranked U.S. equity research analysts across multiple sectors.</p><p>The list includes 24 companies spanning capital goods, consumer, energy, financials, healthcare, materials, media and telecom, and technology sectors. Each selection represents what the bank's analysts view as their most compelling structural and tactical short positions.</p><p>In the technology sector, Intel Corp (NASDAQ:INTC) received an underweight rating from analyst Harlan Sur, while Wix.com Ltd (NASDAQ:WIX) was rated underweight by Alexei Gogolev.</p><p>The healthcare sector features four companies on the list, including Moderna Inc (NASDAQ:MRNA), rated http://www.streetinsider.com/General+News/JPMorgan+analysts+name+top+short+ideas+for+third+quarter+2026/26756237.html Fri, 10 Jul 2026 11:12:30 -0400 BMEA CAR CVI FHI INTC MRNA PINS RIG UDR WIX http://www.streetinsider.com/New+Coverage/Oppenheimer+Assumes+Biomea+Fusion+Inc.+%28BMEA%29+at+Outperform/26680019.html <p>Oppenheimer analyst Leland Gershell assumes coverage on Biomea Fusion Inc. (NASDAQ: BMEA) with a Outperform rating and a price target of $9.00.</p> <p>For an analyst ratings summary and ratings history on Biomea Fusion Inc. <a href="http://www.streetinsider.com/rating_history.php?q=BMEA">click here</a>. For more ratings news on Biomea Fusion Inc. <a href="http://www.streetinsider.com/stock_lookup_news.php?q=BMEA&amp;type=analyst">click here</a>.</p> <p>Shares of Biomea Fusion Inc. closed at $1.23 yesterday.</p> http://www.streetinsider.com/New+Coverage/Oppenheimer+Assumes+Biomea+Fusion+Inc.+%28BMEA%29+at+Outperform/26680019.html Tue, 23 Jun 2026 16:34:55 -0400 BMEA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Faust+Elizabeth/26640970.html si-local-file:///var/storage/secattach/20260612/26640970.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Faust+Elizabeth/26640970.html Fri, 12 Jun 2026 16:16:00 -0400 BMEA O.49924910 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Faust+Elizabeth/26640970.html si-local-file:///var/storage/secattach/20260612/26640970.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Faust+Elizabeth/26640970.html Fri, 12 Jun 2026 16:16:00 -0400 BMEA O.49924910 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+AGUIAR+ERIC/26640977.html si-local-file:///var/storage/secattach/20260612/26640977.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+AGUIAR+ERIC/26640977.html Fri, 12 Jun 2026 16:16:00 -0400 BMEA O.49924910 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+AGUIAR+ERIC/26640977.html si-local-file:///var/storage/secattach/20260612/26640977.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+AGUIAR+ERIC/26640977.html Fri, 12 Jun 2026 16:16:00 -0400 BMEA O.49924910 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Ray+Sumita/26640982.html si-local-file:///var/storage/secattach/20260612/26640982.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Ray+Sumita/26640982.html Fri, 12 Jun 2026 16:16:00 -0400 BMEA O.49924910 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Ray+Sumita/26640982.html si-local-file:///var/storage/secattach/20260612/26640982.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Ray+Sumita/26640982.html Fri, 12 Jun 2026 16:16:00 -0400 BMEA O.49924910 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Averill+Julianne/26640960.html si-local-file:///var/storage/secattach/20260612/26640960.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Averill+Julianne/26640960.html Fri, 12 Jun 2026 16:15:00 -0400 BMEA O.49924910 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Averill+Julianne/26640960.html si-local-file:///var/storage/secattach/20260612/26640960.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10++Filed+by%3A+Averill+Julianne/26640960.html Fri, 12 Jun 2026 16:15:00 -0400 BMEA O.49924910 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10/26632553.html si-local-file:///var/storage/secattach/20260611/26632553.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10/26632553.html Thu, 11 Jun 2026 07:12:00 -0400 BMEA O.49924910 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10/26632553.html si-local-file:///var/storage/secattach/20260611/26632553.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biomea+Fusion%2C+Inc.+++++++For%3A+Jun+10/26632553.html Thu, 11 Jun 2026 07:12:00 -0400 BMEA O.49924910 http://www.streetinsider.com/Press+Releases/Biomea+Fusion+Presents+New+Clinical+and+Translational+Data+for+Icovamenib+at+the+American+Diabetes+Association+%28%E2%80%9CADA%E2%80%9D%29+86th+Scientific+Sessions+and+Announces+Expansion+of+Ongoing+Phase+I+BMF-650+S/26612611.html <p align="center"><em>•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes </em><br /><em>• Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced </em><br /><em>• Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor http://www.streetinsider.com/Press+Releases/Biomea+Fusion+Presents+New+Clinical+and+Translational+Data+for+Icovamenib+at+the+American+Diabetes+Association+%28%E2%80%9CADA%E2%80%9D%29+86th+Scientific+Sessions+and+Announces+Expansion+of+Ongoing+Phase+I+BMF-650+S/26612611.html Fri, 05 Jun 2026 19:32:00 -0400 BMEA http://www.streetinsider.com/Globe+Newswire/Biomea+Fusion+Presents+New+Clinical+and+Translational+Data+for+Icovamenib+at+the+American+Diabetes+Association+%28%E2%80%9CADA%E2%80%9D%29+86th+Scientific+Sessions+and+Announces+Expansion+of+Ongoing+Phase+I+BMF-650+S/26612611.html <p align="center"><em>•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes </em><br /><em>• Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced </em><br /><em>• Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor http://www.streetinsider.com/Globe+Newswire/Biomea+Fusion+Presents+New+Clinical+and+Translational+Data+for+Icovamenib+at+the+American+Diabetes+Association+%28%E2%80%9CADA%E2%80%9D%29+86th+Scientific+Sessions+and+Announces+Expansion+of+Ongoing+Phase+I+BMF-650+S/26612611.html Fri, 05 Jun 2026 19:32:00 -0400 BMEA http://www.streetinsider.com/Corporate+News/Biomea+Fusion+partners+with+University+of+Leicester+for+obesity+study/26595748.html <p>Biomea Fusion Inc. (NASDAQ: BMEA) announced a research collaboration with the University of Leicester to evaluate its investigational drug icovamenib in combination with semaglutide for obesity treatment.</p><p>The study will be conducted as part of the University of Leicester's ongoing OPAL platform trial, led by Professors Melanie Davies and Thomas Yates at the Leicester Diabetes Centre. The randomized, double-blind trial will assess whether adding icovamenib to GLP-1 therapy enhances weight loss effects compared to semaglutide alone.</p><p>The experimental arm will evaluate icovamenib at 100 mg daily for 12 weeks combined with low-dose semaglutide for 24 weeks versus semaglutide alone for 24 weeks http://www.streetinsider.com/Corporate+News/Biomea+Fusion+partners+with+University+of+Leicester+for+obesity+study/26595748.html Wed, 03 Jun 2026 08:03:50 -0400 BMEA http://www.streetinsider.com/Press+Releases/Biomea+Fusion+Announces+Research+Collaboration+with+University+of+Leicester+to+Evaluate+Icovamenib+in+Combination+with+Semaglutide+in+Obesity/26595536.html <ul><li style="text-align:center;"><em>Collaboration will Assess the Potential Impact of the Combination of Icovamenib and Semaglutide on Physical Function, Body Weight, Body Composition, Muscle Health and Metabolic Outcomes</em></li><li style="text-align:center;"><em>Late-Breaking Preclinical Findings at the American Diabetes Association Annual Meeting June 5-8 Highlighting Potential Mechanisms through which Icovamenib may Support Metabolic Health<br /><br /></em></li></ul> <p>SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced a collaboration with the University of Leicester as part of the ongoing platform research study titled <em>Investigating and Optimizing http://www.streetinsider.com/Press+Releases/Biomea+Fusion+Announces+Research+Collaboration+with+University+of+Leicester+to+Evaluate+Icovamenib+in+Combination+with+Semaglutide+in+Obesity/26595536.html Wed, 03 Jun 2026 08:00:00 -0400 BMEA